This condition is often caused by the side effects of medication, mercury toxicity, restricted blood flow in the brain, a brain tumor or traumatic brain injury
The exact mechanisms are still being studied, but the clinical benefit is clearly established in multiple large trials
Meanwhile, according to a 2026 study, patients in the dataset who took Wegovy were 4.74 times more likely to develop ION (Ischemic optic neuropathy) than those who took another brand of GLP-1 drugs
Chc hn bn nghe nhiu n cm t ung b in gii dng trong cc trng hp c th mt nc, st cao, tiu chy hoc sau khi hot ng th cht mnh
Riffault B, Kourdougli N, Dumon C, Ferrand N, Buhler E, Schaller F, et al